The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> Analyst Interviews >> August 12, 2016

Critical Demand for Innovation in Pharma and Biotech

Brozak, Steve
Steve Brozak is the Managing Partner and President of WBB Securities, LLC, an investment bank and financial analytical firm engaged in the biotechnology, pharmaceutical and medical device sectors. Before co-founding WBB Securities, LLC, Mr. Brozak held positions in finance at several prominent Wall Street firms including Alex. Brown & Sons, Dean Witter, Cowen & Company and Salomon Brothers. As the firm's Senior Equity Analyst, Mr. Brozak has been distinguished from his peers year after year for his investment acumen and equity research performance by each of the major analyst ranking systems. Most recently in 2013, Mr. Brozak was selected as the number two-ranked analyst in the pharmaceuticals sector by the StarMine/Financial Times Industry Analyst Awards system. The Wall Street Journal distinguished Mr. Brozak as its Best on the Street medical equipment and supplies financial analyst in its 19th Annual Best on the Street Survey published in 2011. In 2010, Mr. Brozak received StarMine Thompson Reuters/Financial Times Best Brokerage Analyst award for his selection of top-performing companies in the biotechnology space. With a 30-year track record in banking and analysis in the life sciences space, Mr. Brozak is a highly sought after media commentator on the life sciences sector by prominent news agencies on the web, television, and in print media. As a speaker, Mr. Brozak is invited to address major institutional audiences at numerous industry conferences and summits to share his ideas and expertise in identifying trends in the health care and life sciences space. Mr. Brozak is a regular guest commentator for Bloomberg Television and CNBC, where he is asked to share his opinions on health care companies and trends. Mr. Brozak also frequently writes for Forbes and ABC News to express his latest views on the life sciences sector. Mr. Brozak served in the United States Marine Corps and on the Secretary of the Navy's Navy and Marine Corps Retiree Council, where he focused on health care, benefits and other veteran issues. Mr. Brozak received a B.A. and MBA from Columbia University and his Doctorate in Medical Humanities from Drew University. He also holds FINRA licenses 3, 7, 8, 24, 63, 65, 79, 86, 87 and 99. Profile
TWST: Describe your firm and your role in it, if you would.

Mr. Brozak: We are an independent broker/dealer that specializes in biotechnology, medical device,

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)
Interview with the Founder and Executive Chairman: Organovo Holdings Inc. (NASDAQ:ONVO)
Interview with the Co-Founder and CEO: Equillium Inc. (NASDAQ:EQ)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Electric Cars and AI Fuel Long-Term Electricity Demand
Separating the Real Winners and Losers in the AI Boom
Generating Dividend Yield That’s Not Correlated to Interest Rates
ANALYST INTERVIEWS
Robust M&A Activity Provides Tailwind to Biotech Sector
Seeking Out Game Changers in Re-Emerging Biotech Sector
Obesity Drugmakers Still a ‘Buy’ Despite Lofty Valuations
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy